ERBB2 and ovarian neoplasm: The experimental results suggested that we successfully constructed HER2 CAR-Ms and CD47 CAR-Ms and verified the targeted phagocytosis effect on ovarian tumor cells in vitro (Additional file 1: Fig. S2).